On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing

Publisher： John Wiley & Sons Inc

E-ISSN： 1748-720x|43|1|134-142

ISSN： 1073-1105

Source： THE JOURNAL OF LAW, MEDICINE & ETHICS, Vol.43, Iss.1, 2015-03, pp. : 134-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CONSORT recommendations for reporting harms in clinical trials

By  

Reactions Weekly, Vol. 1, Iss. 1031, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

CONSORT recommendations for reporting harms in clinical trials

By  

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Cancer genome sequencing and functional genomics: from translational to clinical medicine

By Roukos Dimitrios H  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1371-1374

Future Medicine

Access to resources Recommend Favorite

Considering Actionability at the Participant's Research Setting Level for Anticipatable Incidental Findings from Clinical Research

By  

THE JOURNAL OF LAW, MEDICINE & ETHICS, Vol. 43, Iss. 3, 2015-09 ,pp. : 619-632

John Wiley & Sons Inc

Access to resources Recommend Favorite

Whole-genome sequencing in pharmacogenetics

By Urban Thomas J  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 345-348

Future Medicine

Access to resources Recommend Favorite